The Cooper Companies, Inc. (LON:0I3I)
London · Delayed Price · Currency is GBP · Price in USD 81.54
-0.96 (-1.16%)
Feb 12, 2026, 4:58 PM GMT
The Cooper Companies Market Cap
The Cooper Companies has a market cap or net worth of 11.93 billion as of February 12, 2026. Its market cap has decreased by -24.54% in one year.
Market Cap
11.93B
Enterprise Value
13.89B
Revenue
3.12B
Ranking
n/a
PE Ratio
41.79
Stock Price
81.54
Market Cap Chart
Since May 10, 1983, The Cooper Companies's market cap has increased from 264.65M to 11.93B, an increase of 4,407.54%. That is a compound annual growth rate of 9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.93B | -0.04% |
| Dec 31, 2025 | 11.93B | -18.57% |
| Dec 31, 2024 | 14.66B | -0.40% |
| Dec 29, 2023 | 14.71B | 8.64% |
| Dec 30, 2022 | 13.54B | -11.39% |
| Dec 31, 2021 | 15.29B | 16.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |